Aurora Cannabis/$ACB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Aurora Cannabis

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.

Ticker

$ACB
Sector
Primary listing

Employees

1,073

Headquarters

Edmonton, Canada

Aurora Cannabis Metrics

BasicAdvanced
$301M
-
-$0.23
3.44
-

What the Analysts think about Aurora Cannabis

Analyst ratings (Buy, Hold, Sell) for Aurora Cannabis stock.

Bulls say / Bears say

In Q1 FY2026, Aurora reported a 37% year-over-year increase in global medical cannabis net revenue to $64.8 million, driven by an 85% surge in international markets, underscoring strong global demand. (Nasdaq)
In fiscal 2025, the company achieved record adjusted EBITDA of $49.7 million (261% YoY growth) and generated $9.9 million in positive free cash flow, highlighting robust profitability and cash generation. (PR Newswire)
As of Q1 FY2026, Aurora operates its cannabis business debt-free with approximately $186 million in cash on hand, providing financial flexibility for strategic growth. (PR Newswire)
Aurora warned that global cannabis revenue would temporarily decline due to reduced international sales, prompting a more than 17% stock drop and indicating volatility in key markets. (Investopedia)
In Q1 FY2026, consumer cannabis net revenue fell 32% year-over-year to $7.9 million as Aurora prioritized its medical segment, revealing weakness in its consumer business. (Nasdaq)
On June 18, 2025, Aurora’s shares plunged 20.4% and traded about 35% below their 52-week high, reflecting ongoing market skepticism and valuation headwinds. (MarketWatch)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.

Aurora Cannabis Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Aurora Cannabis Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ACB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs
Buy Aurora Cannabis stock | $ACB Share Price | Lightyear